Adocia - Company & Market Research Reports

Adocia is a biotechnology company which focuses on producing treatments for diabetes. It was founded in 2005, and headquartered in Lyon, France. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas. There pipeline of products include: Biochaperone Lispro, Biochaperone Combo, Hinsbet, Biochaperone Human Glucagon, Biochaperone Glargine GLP-1, Biochaperone Prandial combinations for T1D.

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020 - Product Thumbnail Image

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

  • Report
  • 125 Pages
From
Diabetes & Obesity Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • Report
  • 560 Pages
From
Prefilled Syringes Market (4th Edition), 2017-2026 - Product Thumbnail Image

Prefilled Syringes Market (4th Edition), 2017-2026

  • Report
  • 525 Pages
From
Hypoglycemia - Pipeline Review, H2 2018 - Product Thumbnail Image

Hypoglycemia - Pipeline Review, H2 2018

  • Report
  • 78 Pages
From
Global Diabetic Therapeutic Market 2017-2021 - Product Thumbnail Image

Global Diabetic Therapeutic Market 2017-2021

  • Report
  • 167 Pages
From
Global Metabolic Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Metabolic Disorders Therapeutics Market 2016-2020

  • Report
  • 163 Pages
From
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations - Product Thumbnail Image

Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

  • Report
  • 160 Pages
From
Global Endocrinology Drugs Market 2016-2020 - Product Thumbnail Image

Global Endocrinology Drugs Market 2016-2020

  • Report
  • 118 Pages
From
Global Type 2 Diabetes Market 2016-2020 - Product Thumbnail Image

Global Type 2 Diabetes Market 2016-2020

  • Report
  • 122 Pages
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Report
  • 1109 Pages
From
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018

  • Report
  • 576 Pages
From
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018 - Product Thumbnail Image

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018

  • Report
  • 49 Pages
From
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2017

  • Report
  • 595 Pages
From
Type 2 Diabetes - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2017

  • Report
  • 1126 Pages
From
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026

  • Report
  • 377 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Obesity - Pipeline Review, H1 2018 - Product Thumbnail Image

Obesity - Pipeline Review, H1 2018

  • Report
  • 526 Pages
From
Global Next-Generation Biologics Market 2016-2020 - Product Thumbnail Image

Global Next-Generation Biologics Market 2016-2020

  • Report
  • 124 Pages
From
Loading Indicator
adroll